Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
DELL - Dell Technologies Inc - Stock Price Chart
TickerDELL [NYSE]
CompanyDell Technologies Inc
CountryUSA
IndustryComputer Hardware
Market Cap88.00BEPS (ttm)4.37
P/E28.53EPS this Y5.43%
Forward P/E14.59EPS next Y13.60%
PEG35.23EPS past 5Y-
P/S0.99EPS next 5Y0.81%
P/B-EPS Q/Q90.33%
Dividend1.38%Sales Q/Q-10.93%
Insider Own66.52%Inst Own28.26%
Insider Trans-1.44%Inst Trans-1.10%
Short Float4.16%EarningsFeb 29/a
Analyst Recom1.90Target Price118.26
Avg Volume4.61M52W Range35.96 - 94.99
Mar-01-24Reiterated TD Cowen Market Perform $75 → $105
Dell Technologies, Inc. is a holding company, which engages in the provision of information technology hardware, software, and service solutions through its subsidiaries. It operates through the following segments: Infrastructure Solutions Group (ISG), Client Solutions Group (CSG), and VMware. The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment consists of sales to commercial and consumer customers of desktops, thin client products, and notebooks. The VMware segment provides compute, cloud management, networking and security, storage and availability, and other end-user computing offerings. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SLTA V (GP), L.L.C.DirectorJan 16Sale78.813,179,972250,626,6310Jan 17 08:04 PM
SLTA IV (GP), L.L.C.DirectorJan 16Sale78.813,179,972250,626,6310Jan 17 08:05 PM
SLTA V (GP), L.L.C.DirectorJan 12Sale79.43239,11218,992,2360Jan 17 08:04 PM
SLTA IV (GP), L.L.C.DirectorJan 12Sale79.43239,11218,992,2360Jan 17 08:05 PM
Susan Lieberman Dell Separate 10% OwnerDec 01Option Exercise0.002,500,00002,500,000Dec 05 08:41 AM
MYO - Myomo Inc - Stock Price Chart
TickerMYO [AMEX]
CompanyMyomo Inc
CountryUSA
IndustryMedical Devices
Market Cap106.35MEPS (ttm)-0.50
P/E-EPS this Y83.06%
Forward P/E-EPS next Y36.89%
PEG-EPS past 5Y55.58%
P/S5.74EPS next 5Y-0.47%
P/B9.65EPS Q/Q85.65%
Dividend-Sales Q/Q28.01%
Insider Own24.22%Inst Own36.32%
Insider Trans1.02%Inst Trans-0.51%
Short Float2.74%EarningsMar 07/a
Analyst Recom1.00Target Price5.96
Avg Volume600.76K52W Range0.37 - 5.58
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorNov 20Buy3.1050,000155,000136,499Dec 14 07:46 PM
Morris Milton MayoDirectorSep 08Buy1.0615,00015,86777,933Sep 11 05:05 PM
GUDONIS PAUL RChief Executive OfficerAug 30Buy0.7448,40036,039878,245Aug 31 06:26 PM
GUDONIS PAUL RChief Executive OfficerAug 29Buy0.7837,00028,797829,845Aug 30 04:22 PM
HENRY DAVID AChief Financial OfficerAug 29Buy0.6041,66625,000352,193Aug 30 04:36 PM
CYTO - Altamira Therapeutics Ltd - Stock Price Chart
TickerCYTO [NASD]
CompanyAltamira Therapeutics Ltd
CountryBermuda
IndustryBiotechnology
Market Cap3.84MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.79%
P/S-EPS next 5Y-
P/B-EPS Q/Q87.98%
Dividend-Sales Q/Q-
Insider Own0.00%Inst Own0.49%
Insider Trans-Inst Trans30.91%
Short Float3.83%EarningsSep 12/b
Analyst Recom1.00Target Price287.34
Avg Volume420.66K52W Range1.61 - 101.60
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
SG - Sweetgreen Inc - Stock Price Chart
TickerSG [NYSE, RUT]
CompanySweetgreen Inc
CountryUSA
IndustryRestaurants
Market Cap1.84BEPS (ttm)-1.01
P/E-EPS this Y43.35%
Forward P/E-EPS next Y19.75%
PEG-EPS past 5Y-12.71%
P/S3.15EPS next 5Y27.00%
P/B3.82EPS Q/Q49.78%
Dividend-Sales Q/Q29.06%
Insider Own15.00%Inst Own77.29%
Insider Trans-2.10%Inst Trans17.75%
Short Float15.15%EarningsFeb 29/a
Analyst Recom1.89Target Price15.00
Avg Volume1.68M52W Range6.10 - 16.58
Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reback MitchCHIEF FINANCIAL OFFICERFeb 27Sale12.0110,444125,432439,059Feb 29 06:30 PM
Gemperle AdrienneCHIEF PEOPLE OFFICERFeb 22Sale11.3312,442140,968127,251Feb 23 05:24 PM
Neman JonathanCHIEF EXECUTIVE OFFICERFeb 20Sale11.555,00057,7500Feb 21 05:04 PM
Reback MitchCHIEF FINANCIAL OFFICERFeb 16Sale12.326,55380,733449,503Feb 21 04:43 PM
Gemperle AdrienneCHIEF PEOPLE OFFICERFeb 16Sale12.324,28652,804139,693Feb 21 04:46 PM
EVBG - Everbridge Inc - Stock Price Chart
TickerEVBG [NASD, RUT]
CompanyEverbridge Inc
CountryUSA
IndustrySoftware - Application
Market Cap1.47BEPS (ttm)-1.43
P/E-EPS this Y22.54%
Forward P/E18.60EPS next Y5.46%
PEG-EPS past 5Y6.55%
P/S3.27EPS next 5Y48.40%
P/B4.85EPS Q/Q-231.82%
Dividend-Sales Q/Q-1.17%
Insider Own6.02%Inst Own85.87%
Insider Trans-0.78%Inst Trans-3.72%
Short Float2.10%EarningsFeb 26/a
Analyst Recom3.00Target Price30.80
Avg Volume1.10M52W Range18.50 - 35.50
Everbridge, Inc. engages in the development of software solutions for critical event management and enterprise safety applications that automate and accelerate an organization's operational response to critical events. Its SaaS-based CEM platform enables customers to aggregate and assess threat data, locate people at risk and responders able to assist, automate the execution of pre-defined communications processes, and track progress on executing response plans. The company was founded by Cinta Putra, Steve Kirchmeier, Patrick Stuver and James Keene in 2002 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Barney Bryan ReedCHIEF PRODUCT OFFICERFeb 05Sale28.1173020,52017,491Feb 06 04:40 PM
Brickley PatrickEVP and CFOFeb 01Sale22.796,360144,971124,985Feb 01 04:28 PM
HUFF PHILLIP EVP, Chief Accounting OfficerFeb 01Sale22.793137,13511,237Feb 01 04:29 PM
Barney Bryan ReedChief Product OfficerJan 02Sale23.527,509176,64618,221Jan 02 05:29 PM
HUFF PHILLIP EVP, Chief Accounting OfficerJan 02Sale23.521503,52910,778Jan 02 05:37 PM
EIGR - Eiger BioPharmaceuticals Inc - Stock Price Chart
TickerEIGR [NASD]
CompanyEiger BioPharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap10.36MEPS (ttm)-58.82
P/E-EPS this Y34.91%
Forward P/E-EPS next Y68.84%
PEG-EPS past 5Y13.71%
P/S0.71EPS next 5Y-
P/B-EPS Q/Q33.96%
Dividend-Sales Q/Q-20.25%
Insider Own11.78%Inst Own42.45%
Insider Trans173.55%Inst Trans168.90%
Short Float3.23%EarningsNov 09/a
Analyst Recom1.00Target Price30.00
Avg Volume9.08K52W Range5.12 - 57.30
Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KAYNE RICHARD A10% OwnerNov 02Buy0.3023,3986,9665,375,225Nov 02 09:21 PM
KAYNE RICHARD A10% OwnerNov 01Buy0.28100,00027,9705,351,827Nov 02 09:21 PM
KAYNE RICHARD A10% OwnerOct 31Buy0.24154,84137,8805,251,827Nov 02 09:21 PM
KAWAS LEEN10% OwnerOct 31Buy0.2624,3326,3754,391,432Nov 02 09:14 PM
Mayer Eldon C. IIIEx VP & Chief Commerc. OfficerMar 17Sale1.074,3954,70456,073Mar 21 09:00 PM
ROOT - Root Inc - Stock Price Chart
TickerROOT [NASD]
CompanyRoot Inc
CountryUSA
IndustryInsurance - Property & Casualty
Market Cap571.01MEPS (ttm)-10.23
P/E-EPS this Y10.71%
Forward P/E-EPS next Y34.80%
PEG-EPS past 5Y-15.84%
P/S1.25EPS next 5Y41.30%
P/B3.42EPS Q/Q65.61%
Dividend-Sales Q/Q173.21%
Insider Own60.95%Inst Own26.80%
Insider Trans0.02%Inst Trans4.57%
Short Float17.03%EarningsFeb 21/a
Analyst Recom2.00Target Price16.88
Avg Volume419.07K52W Range3.31 - 34.41
Mar-01-24Upgrade Jefferies Hold → Buy $10 → $40
Root, Inc. is a technology insurance company, which engages in the provision of insurance services. It offers mobile telematics and technology platforms to segment individual risk based on complex behavioral data and customer experience to make pricing decisions and grow businesses. It provides insurance products and services in the United States. The company was founded by Alexander E. Timm and Daniel Manges in February 2015 and is headquartered in Columbus, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Allison JonathanChief Administrative OfficerDec 05Sale14.184,00056,70076,766Dec 05 04:40 PM
Allison JonathanChief Administrative OfficerDec 01Sale11.104,00044,41280,766Dec 05 04:40 PM
Allison JonathanChief Administrative OfficerNov 15Sale9.888,00079,02484,780Nov 17 04:27 PM
Bonakdarpour MahtiyarChief Technology OfficerNov 14Buy9.8911,342112,172305,955Nov 15 04:17 PM
Bonakdarpour MahtiyarChief Technology OfficerNov 13Buy10.336,15863,588294,613Nov 15 04:17 PM
RGNX - Regenxbio Inc - Stock Price Chart
TickerRGNX [NASD, RUT]
CompanyRegenxbio Inc
CountryUSA
IndustryBiotechnology
Market Cap941.47MEPS (ttm)-6.03
P/E-EPS this Y35.91%
Forward P/E-EPS next Y50.37%
PEG-EPS past 5Y-
P/S10.43EPS next 5Y13.60%
P/B2.99EPS Q/Q-3.25%
Dividend-Sales Q/Q-29.13%
Insider Own10.44%Inst Own87.29%
Insider Trans-2.57%Inst Trans-3.36%
Short Float10.49%EarningsFeb 27/a
Analyst Recom1.90Target Price34.40
Avg Volume647.59K52W Range11.83 - 25.32
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mills Kenneth T.President and CEOFeb 14Option Exercise3.7615,00056,400423,035Feb 16 06:28 PM
Mills Kenneth T.President and CEOFeb 14Sale16.7615,000251,349408,035Feb 16 06:28 PM
Mills Kenneth T.President and CEOJan 16Option Exercise3.7645,000169,200453,035Jan 18 06:39 PM
Mills Kenneth T.President and CEOJan 16Sale15.1845,000682,992408,035Jan 18 06:39 PM
PAKOLA STEVEChief Medical OfficerJan 03Sale17.3917,237299,789107,192Jan 04 04:23 PM
PRFX - PainReform Ltd - Stock Price Chart
TickerPRFX [NASD]
CompanyPainReform Ltd
CountryIsrael
IndustryDrug Manufacturers - Specialty & Generic
Market Cap4.68MEPS (ttm)-7.65
P/E-EPS this Y39.63%
Forward P/E-EPS next Y28.28%
PEG-EPS past 5Y-28.81%
P/S-EPS next 5Y-
P/B0.55EPS Q/Q-17.35%
Dividend-Sales Q/Q-
Insider Own21.51%Inst Own9.28%
Insider Trans0.00%Inst Trans1.09%
Short Float0.30%EarningsNov 15/a
Analyst Recom1.00Target Price11.00
Avg Volume23.41K52W Range1.82 - 26.41
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
HSAI - Hesai Group ADR - Stock Price Chart
TickerHSAI [NASD]
CompanyHesai Group ADR
CountryChina
IndustryAuto Parts
Market Cap424.02MEPS (ttm)-0.53
P/E-EPS this Y52.35%
Forward P/E-EPS next Y71.88%
PEG-EPS past 5Y-
P/S1.73EPS next 5Y-
P/B0.95EPS Q/Q-89.54%
Dividend-Sales Q/Q26.21%
Insider Own17.93%Inst Own15.88%
Insider Trans0.00%Inst Trans-
Short Float0.85%EarningsMar 11/a
Analyst Recom1.44Target Price14.73
Avg Volume612.75K52W Range3.28 - 19.59
Hesai Group engages in the development, manufacture and sale of 3-dimensional light detection and ranging solutions. Its operational segments include LiDAR and Gas Detection. The firm's products enable a broad spectrum of applications across autonomous vehicle fleets providing passenger & freight mobility services, passenger or commercial vehicles with advanced driver assistance systems, and other applications such as last-mile delivery robots, street sweeping robots and logistics robots in restricted areas. The company was founded by Yi Fan Li, Kai Sun and Shao Qing Xing in October 2014 and is headquartered in Shanghai, China.
12345671020